Influenza B M1 Antibody (5K167): sc-71379

Influenza B M1 Antibody (5K167) is a mouse monoclonal IgG1 antibody that detects Influenza B M1 protein of Influenza B Virus origin by western blotting (WB) and immunofluorescence (IF). Anti-Influenza B M1 antibody (5K167) is available as the non-conjugated format. Influenza B M1 protein plays a crucial role in the viral life cycle, primarily functioning as a structural protein that forms the matrix layer beneath the viral envelope, which is essential for maintaining the integrity and shape of the virus. This matrix protein is vital for the assembly and budding of new virions from infected host cells, thereby facilitating viral spread. Understanding Influenza B M1 protein function is important not only for comprehending viral replication but also for developing targeted antiviral therapies and vaccines. Influenza viruses, including Influenza A, B, and C, are RNA viruses belonging to the Orthomyxoviridae family and are known for their ability to undergo antigenic drifts and shifts, which enable them to evade host immune response. These viruses transcribe and replicate their genomes within the nuclei of infected cells, relying on nucleocytoplasmic transport of viral ribonucleoproteins during replication. Influenza B comprises several viral proteins, including Influenza B NP (nucleoprotein), Influenza B HA (hemagglutinin), Influenza B M1 (matrix protein), and Influenza B NA (neuraminidase), all of which are essential for viral functions such as DNA replication, transcription, RNA processing, and protein synthesis. While Influenza A is known to cause pandemics, Influenza B typically results in milder illnesses, such as common flu, and Influenza C can lead to mild or asymptomatic disease.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

Influenza B M1 Antibody (5K167) References:

1. Coinfection with influenza B virus does not affect association of Neisseria meningitidis with human nasopharyngeal mucosa in organ culture.  |  Read, RC., et al. 1999. Infect Immun. 67: 3082-6. PMID: 10338524
2. Influenza B virus in seals.  |  Osterhaus, AD., et al. 2000. Science. 288: 1051-3. PMID: 10807575
3. Influenza B and C virus NEP (NS2) proteins possess nuclear export activities.  |  Paragas, J., et al. 2001. J Virol. 75: 7375-83. PMID: 11462009
4. Influenza A and B virus infections in children.  |  Peltola, V., et al. 2003. Clin Infect Dis. 36: 299-305. PMID: 12539071
5. Epidemics of two Victoria and Yamagata influenza B lineages in Yamagata, Japan.  |  Mizuta, K., et al. 2004. Epidemiol Infect. 132: 721-6. PMID: 15310174
6. Detection and characterization of new influenza B virus variants in 2002.  |  Chi, XS., et al. 2005. J Clin Microbiol. 43: 2345-9. PMID: 15872264
7. Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains.  |  Krystal, M., et al. 1983. Proc Natl Acad Sci U S A. 80: 4527-31. PMID: 6192436
8. Serological diagnosis of influenza B virus infection: comparison of an enzyme-linked immunosorbent assay and the hemagglutination inhibition test.  |  Turner, R., et al. 1982. J Clin Microbiol. 15: 824-9. PMID: 7047553